Theratechnologies (THTX) Stock Analysis
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
What Theratechnologies does
Theratechnologies Inc. is a biopharmaceutical firm dedicated to creating and marketing a range of treatments aimed at fulfilling critical medical requirements across the United States, Canada, and Europe. Its current product portfolio includes EGRIFTA and EGRIFTA SV, designed to diminish excessive abdominal fat in HIV-positive individuals experiencing lipodystrophy. Additionally, it markets Trogarzo, an injectable formulation of ibalizumab, which targets multidrug-resistant HIV-1 infections. Within its development pipeline are F8 Formulation, intended for addressing lipodystrophy in people with HIV; TH1902, currently undergoing Phase 1/Part A clinical trials for triple-negative breast cancer; and TH1904, aimed at treating ovarian cancer. Established in 1993, the company maintains its main office in Montreal, Canada.
Key metrics
ETFs linked to THTX
Broad-market and Healthcare sector ETFs an investor holding Theratechnologies is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how THTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze THTX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Theratechnologies?
- Theratechnologies trades under the ticker THTX on NASDAQ.
- Which exchange is THTX listed on?
- THTX is listed on NASDAQ.
- What sector does Theratechnologies operate in?
- Theratechnologies is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
- How can PortView help analyze THTX in a portfolio?
- PortView shows THTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.